Connect with us

News

Mpox: NCDC Confirms Six More Cases 

Published

on

Mpox: NCDC Confirms Six More Cases 

The Nigeria Centre for Disease Control (NCDC) has confirmed an additional six cases of the Mpox disease in Nigeria, News About Nigeria reports. 

The centre disclosed this in its recent situation report on Monday, stating that no death has been recorded from the disease from the 22nd-29th of September 2024.

According to NCDC, the states affected in the reporting week are Plateau with two cases and Delta, FCT, Katsina, and Imo, with one case each.

It added that the number of cases recorded indicated an increase from the three recorded in the previous week.

It further noted that 25 states and the Federal Capital Territory (FCT) have recorded at least one confirmed case across 57 local government areas since the beginning of the outbreak in 2024.

The report revealed that from September 2017 to date, Nigeria has reported a total number of 5054 suspected cases with 1,170 confirmed cases, representing a confirmation rate of 23.3 percent.

It stated that the outbreak has resulted in 17 fatalities, with men predominantly affected (70 percent).

Geographically, the disease has spread extensively across the country, affecting all 36 states and FCT, indicating widespread distribution.

The Centre also stated that it is actively coordinating the response to the mpox outbreak through its National Mpox multi-sectoral and multi-partner Emergency Operation Centre (EOC).

This collaborative effort, according to the NCDC, involves various stakeholders to ensure a comprehensive approach to stemming the spread of the disease.

It added that the response encompasses surveillance and reporting of suspected and confirmed cases nationwide, providing guidance and support for case management, conducting public awareness campaigns, and partnering with state governments, health agencies, and partners.

Mpox is an acute illness that typically begins with fever, severe headache, swollen lymph nodes, back pain, muscle pain, and extreme fatigue.